Latest Publications

Share:

Sandoz Was Disinvited to the Patent Dance: The Federal Circuit's First Interpretation of the BPCIA Will Have to Wait

Since the 1984 enactment of the Drug Price Competition and Patent Term Restoration Act, Hatch-Waxman litigation has dominated the sphere of life-sciences patent litigation. The battle between proprietary and generic...more

12/19/2014 - Biosimilars BPCIA FDA Generic Drugs Hatch-Waxman Life Sciences Patent Litigation Patents Pharmaceutical Patents Popular Sandoz

Ruling in Eastern District of Texas Sets the Stage for the Federal Circuit to Revisit Fresenius v. Baxter

Versata Software, Inc. et al. v. SAP America, Inc. et al., Case No. 2:07cv153-RSP (E.D. Tex.) - Versata v. SAP has been a dispute that the patent bar has followed with interest because it spawned the very first Covered...more

4/24/2014 - America Invents Act Covered Business Method Patents Fresenius Patent Litigation Patent Trial and Appeal Board

2 Results
|
View per page
Page: of 1